Popular Posts

Conclusion

Posted by Ares Wednesday, December 1, 2010 2 comments

Gene therapies are currently being studied in more than 50 clinical trials. This method holds considerable promise for many inborn errors of metabolism. Gene therapy for inborn errors of metabolism requires the development of biologically sound strategies for correcting metabolic defects, vectors for controlling the expression of therapeutic genes, and methods for delivering vectors safely to patients.

The efficacy of gene therapy will ultimately need to be assessed and demonstrated relative to conventional therapeutics. While it is widely believed that many inborn errors of metabolism may come to be best treated by gene therapy, these will also be significant advances in the development of conventional pharmaceutical products, biological products such as enzyme replacement, and transplantation, including the potential for inducing tolerance to allogeneic or xenogeneic grafts.
The question “Why gene therapy?”
must be answered by showing that proposed gene therapies are more effective and safer than other therapies,
provide adequate compliance, and are cost-effective relative to other therapies.

The intense social discourse conserning the propriety and etical implications of gene therapy has been largely resolved with the realization that somatic gene therapy is in principle no different than replacing deficient functions with enzyme replacement therapy or organ transplantation. Because of intense social concern generated by gene therapy, clinical trials in the United States are reviewed in public by the Recombinant Advisory Committee (RAC) of the National Institute of Health as well as by the Food and Drug Administration (FDA) through the traditional IND (Investigational Drug) process. A similar review process has been established by many European countries and the European Union,

The first clinical trials using retroviral vectors demonstrated the feasibility and social and regulatory acceptance of gene transfer into human subject. The initial trials have greatly expanded interest in gene therapy and led to a more focused analysis of the potential clinical indications for gene therapy.
To date, the number of patients treated is still too small to fully assess the safety or efficacy of either retroviral vectors or any specific gene therapy.
Gene replacement is now commonly performed in research laboratories studying inborn errors of metabolism,

Since the commencement of the first clinical trial involving gene transfer into human subjects in 1989, more than 100 patients have been treated and more than 100 patients have been treated and more than 70 clinical trials are underway.
Many of the ongoing clinical trials are gene marking trials, in which genes are introduced into cells prior to transplantation to study their fate and function. The majority of current clinical trials are aimed at gene therapy for cancer.

It is also possible to delivery DNA vectors directly to cells withouth the use of viruses. This involves the application of pharmaceutical methods for drug delivery to target DNA vectors to specific cells after direct administration to patients and to enhance the process by which DNA vectors are taken into cells and traffick to the nucleous were transcription can take place.
In particular, pharmaceutical experience with liposomes and other particulate drug carriers may be employed indrug delivery.
Various different approaches have been described for DNA delivery,
including the use of purified DNA administered directly into the body by intramuscular injection, the use of ballistic particles coated with DNA,

Organ transplantation in itself o form of gene therapy in which alloogenic cells containing a normal gene are implanted into the body.

The initial strategies for gene therapy involved the construction of viral vectors in which the expression vector was packaged into a virus particle that was capable of invecting cells. The premise of developing viral vectors was that it might be possible to exploit, for therapeutic purpose, the highly evolved ability of viruses to introduce their genes into certain cells.
To do this, strategies were developed for constructing attenuated or defective

Vectors

Posted by Ares 0 comments

The function of a vector is to control how much of the therapeutic product is produced and where in the body it is produced. Effective gene therapy requires that a therapeutic gene be introduced into cells of the body in a form which allows the gene (DNA) to be transcribed into mRNA, for the mRNA to be properly processed within the cell, for the mRNA to be translated into a protein, and for this protein to be properly modified, to reach the appropriate compartment, and to properly function.
This a achieved by constructing an expression vector

Therapeutic Genes

Posted by Ares 0 comments

In its simplest form, gene therapy for inherited metabolic disease involves introducing a gene into a patient to express an enzyme which the patient lacks because of an inherited genetic defect. Examples of such therapy would be the replacement of phenylalanine hydroxylase in patients with phenylketonuria or the low-density lipoprotein (LDL) receptor in patients with familial hypercholesterolemia. This approach to gene therapy would be applicable to most autosomal recessive diseases and many X-linked diseases where one copy of the normal gene or
in many cases even a fraction of normal enzymatic activity is known to prevent the pathological phenotype of the disorder.

Inborn errors of metabolism, like most disease, have both genetic and environmental components. Current therapy for inborn errors of metabolism focuses on the diagnosis of a genetic defect before the onset of clinical symptoms, which allows changes to be made in the environment of the patient to prevent the progression of the pathological disease process. Dietary therapy and drug therapy are not directed at altering the genetic component of the inborn error of metabolism, but rather its environmental component.

Healthhealth blogs - blog rankingsHealth blogsMy ZimbioTop Blogs blog search directoryBlog Directory & Search engine Health Blogs Sonic Run: Internet Search Engine Active Search Results